Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dijkstra, U.
Right arrow Articles by Renier, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dijkstra, U.
Right arrow Articles by Renier, W.
NEUROLOGY 1984;34:1493
© 1984 American Academy of Neurology


Brief Communication

Friedreich's ataxia

Intravenous pyruvate load to demonstrate a defect in pyruvate metabolism

U. Dijkstra, F. Gabreels, E. Joosten, R. Wevers, K. Lamers, W. Doesburg and W. Renier

From the Institute of Neurology and the Department of Statistical Consultation, St. Radboud University Hospital, Nijmegen, The Netherlands.

Nine patients with typical Friedreich's ataxia had normal levels of pyruvate and lactate in blood, urine, and CSF. Glucose, pyruvate, and lactate levels were also within the reference ranges after oral glucose loading. After intravenous pyruvate loading, the relative increase in blood pyruvate and lactate levels was significantly higher in Friedreich's ataxia patients than in controls. Significant differences between the two groups were also observed in lactate-pyruvate ratios at various times after infusion. The pyruvate loading test can be useful in demonstrating a defect in pyruvate metabolism in Friedreich's ataxia patients.

Address correspondence and reprint requests to Dr. Gahreëls, Institute of Neurology, St. Radboud University Hospital, Box 9101,6500 HB, Nijmegen, The Netherlands.

Accepted for publication March 8, 1984.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. Desagher, J. Glowinski, and J. Premont
Pyruvate Protects Neurons against Hydrogen Peroxide-Induced Toxicity
J. Neurosci., December 1, 1997; 17(23): 9060 - 9067.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Isnard, H. Kalotka, A. Durr, M. Cossee, M. Schmitt, F. Pousset, D. Thomas, A. Brice, M. Koenig, and M. Komajda
Correlation Between Left Ventricular Hypertrophy and GAA Trinucleotide Repeat Length in Friedreich's Ataxia
Circulation, May 6, 1997; 95(9): 2247 - 2249.
[Abstract] [Full Text]


Home page
Arch. Dis. Child.Home page
G Touati, O Rigal, A Lombès, P Frachon, M Giraud, and H O. de Baulny
In vivo functional investigations of lactic acid in patients with respiratory chain disorders
Arch. Dis. Child., January 1, 1997; 76(1): 16 - 21.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by AAN Enterprises, Inc.